Skip to main content

Table 2 Comparison of target dose achievement in HF clinic and other cardiology OPD

From: Guideline-directed medical therapy in heart failure patients: impact of focused care provided by a heart failure clinic in comparison to general cardiology out-patient department

Drugs

Study group

1st month

P value

6th month

P value

12th month

P value

No. of patients

No. of patients

No. of patients

BB

HF clinic (n = 196)

32 (16.32%)

0.06

76 (38.77%)

0.04

116 (59.18%)

0.0001

Other cardiology OPD (n = 170)

16 (9.41%)

46 (27.05%)

58 (34.11%)

ACEI/ARB/ARNI

HF clinic (n = 138)

12 (8.69%)

0.04

66 (47.82%)

0.0001

90 (65.21%)

0.0001

Other cardiology OPD (n = 88)

2 (2.27%)

12 (13.63%)

18 (20.45%)

MRA

HF clinic (n = 152)

140 (92.10%)

0.34

144 (94.73%)

0.35

144 (94.73%)

0.46

Other cardiology OPD (n = 122)

110 (90.16%)

112 (91.80%)

116 (95%)

  1. The attainment of target doses of the disease modifying drugs and their comparison between the study groups
  2. BB beta blockers, ACEI angiotensin converting enzyme inhibitors, ARB angiotensin receptor blockers, ARNI angiotensin receptor neprilysin inhibitor, MRA mineralocorticoid receptor antagonist